PrognosisSurvival AnalysisTumor Markers, BiologicalSurvival RateNeoplasm StagingPredictive Value of TestsDisease-Free SurvivalMultivariate AnalysisRetrospective StudiesKaplan-Meier EstimateProportional Hazards ModelsFollow-Up StudiesTreatment OutcomeImmunohistochemistryLymphatic MetastasisBreast NeoplasmsNeoplasm Recurrence, LocalProspective StudiesTime FactorsRisk FactorsKi-67 AntigenDisease ProgressionAdenocarcinomaTissue Array AnalysisNeoplasm InvasivenessLung NeoplasmsCohort StudiesGene Expression Regulation, NeoplasticAntineoplastic Combined Chemotherapy ProtocolsBiological MarkersNeoplasm MetastasisRisk AssessmentCombined Modality TherapyCarcinoma, Squamous CellRecurrenceNeoplasm GradingCarcinomaMitotic IndexColorectal NeoplasmsROC CurveGene Expression ProfilingNeoplasm ProteinsChemotherapy, AdjuvantAge FactorsReceptors, EstrogenReceptor, erbB-2Carcinoma, Non-Small-Cell LungStomach NeoplasmsPloidiesImmunoenzyme TechniquesSeverity of Illness IndexLymph NodesSensitivity and SpecificityReceptors, ProgesteroneVincristineLiver NeoplasmsMelanomaReproducibility of ResultsBrain NeoplasmsTumor Suppressor Protein p53Lymphoma, Large B-Cell, DiffuseKidney NeoplasmsAnalysis of VarianceChi-Square DistributionOvarian NeoplasmsPrednisoneDNA, NeoplasmRemission InductionCarcinoma, Renal CellCarcinoma, Ductal, BreastReverse Transcriptase Polymerase Chain ReactionCyclophosphamideKarnofsky Performance StatusLeukemia, Myeloid, AcuteAntineoplastic AgentsSkin NeoplasmsEsophageal NeoplasmsDoxorubicinMyocardial InfarctionNeoplastic Cells, CirculatingAcute DiseaseChromosome AberrationsLeukemia, Lymphocytic, Chronic, B-CellIn Situ Hybridization, FluorescenceSurvivalProstatic NeoplasmsNeoplasm, ResidualOligonucleotide Array Sequence AnalysisExercise TestSarcomaCarcinoma, HepatocellularHeart FailureTumor BurdenCytogenetic AnalysisNatriuretic Peptide, BrainLife TablesRNA, MessengerHodgkin DiseaseAntigens, NeoplasmMyelodysplastic Syndromes